Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7611167

Concept 2021-12-01 to
2022-02-28
2021-06-01 to
2022-02-28
As at
2022-02-28
2020-06-01 to
2021-05-31
As at
2021-05-31
As at
2021-02-28
2020-06-01 to
2021-02-28
2020-12-01 to
2021-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
33,583,023,000 JPY
48,714,993,000 JPY
37,835,931,000 JPY
Ordinary profit (loss)
5,794,485,000 JPY
6,067,595,000 JPY
5,422,050,000 JPY
Net assets
46,304,729,000 JPY
41,917,362,000 JPY
41,553,807,000 JPY
Total assets
62,679,967,000 JPY
57,739,365,000 JPY
59,307,351,000 JPY
Basic earnings (loss) per share
85.76
287.81
311.02
271.39
93.09
Diluted earnings per share
Equity-to-asset ratio
0.733 xbrli:pure
0.721 xbrli:pure
0.695 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.